Document is current

Article History

Received: 25 June 2021

Accepted: 17 August 2021

First Online: 31 August 2021

Declarations

:

: The study was performed in compliance with institutional and national ethical standards as well as with the 1964 Helsinki declaration and its later amendments.

: Informed consent was obtained from the patient.

: Informed consent was obtained from the patient for publication of this case report and accompanying images before the patient received treatment.

: KH reports honoraria and research funding from AstraZeneca. MT reports honoraria from AstraZeneca, Ono Pharmaceutical, Boehringer Ingelheim, Bristrol Myers Squibb, Chugai Pharmaceutical, and Novartis Pharma. KN reports honoraria from Eli Lilly, MSD, Kyorin Pharmaceutical, Ono Pharmaceutical, Chugai Pharmaceutical, AstraZeneca, Daiichi Sankyo, and Takeda Pharmaceutical as well as research funding from AstraZeneca, Eisai, Daiichi Sankyo, Boehringer Ingelheim, Ono Pharmaceutical, Syneos Health, Pfizer R&D, IQVIA Services Japan, Bristol Myers Squibb, AbbVie, Taiho Pharmaceutical, A2 Healthcare, MSD, Eli Lilly, and SymBio Pharmaceuticals. All remaining authors declare no conflicts of interest.